High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosis.
Authors:
- C NosCNC Nos
- M ComabellaMCM Comabella
- M TintoreMTM Tintore
- J RioJRJ Rio
- A CodinaACA Codina
- X MontalbanXMX Montalban
- A RoviraARA Rovira
Open Access
- 1 October 1996
- journal article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 61 (4) , 418
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- High-dose intravenous immunoglobulin for multiple sclerosisThe Lancet, 1990
- SERIAL GADOLINIUM ENHANCED MAGNETIC RESONANCE IMAGING IN MULTIPLE SCLEROSISBrain, 1988
- A double-blind controlled trial of high dose methylprednisolone in patients with multiple sclerosis: 1. Clinical effects.Journal of Neurology, Neurosurgery & Psychiatry, 1987
- [Gamma globulin therapy in multiple sclerosis. Theoretical considerations and initial clinical experiences with 7S immunoglobulins in MS therapy].1986